F508del genotype in endoscopic sinus surgery: do differences in outcomes exist between genotypic subgroups?

Area of Science:

• Otolaryngology
• Pulmonology
• Genetics

Background:

• The impact of endoscopic sinus surgery (ESS) on pulmonary function in cystic fibrosis (CF) patients with chronic rhinosinusitis is not well-established, with conflicting prior study results.
• No previous research has specifically examined how CF genotype influences lung function outcomes following ESS.
• This study investigates ESS effects on pulmonary function tests (PFTs) in CF patients, differentiating between F508del homozygotes and heterozygotes.

Purpose of the Study:

• To evaluate the impact of endoscopic sinus surgery (ESS) on pulmonary function in cystic fibrosis (CF) patients.
• To determine if CF genotype (F508del homozygote vs. heterozygote) affects PFT outcomes after ESS.
• To clarify conflicting results in the literature regarding ESS and CF pulmonary function.

Main Methods:

• Retrospective review of 25 CF patients without prior lung transplant who underwent ESS between July 2005 and July 2015.
• Data collection included patient genotype and pre- and postoperative PFT results.
• Patients were categorized by genotype, and PFT outcomes were compared between groups and over time.

Main Results:

• The overall cohort demonstrated a significant improvement in FEV1 at 6 months post-ESS (p = 0.0127).
• Subgroup analysis revealed significant FEV1 improvements at 6 and 12 months in the heterozygous CF genotype group (p = 0.0155 and p = 0.0333, respectively).
• No significant FEV1 improvements were observed in either genotype group compared to baseline at any timepoint.

Conclusions:

• Prior studies on ESS in CF patients may have lacked statistical power due to heterogeneous patient populations lacking genotype stratification.
• This study suggests that genotype-specific analysis is crucial for understanding ESS outcomes in CF.
• Stratifying CF patients by genotype or disease severity may reveal significant differences in response to ESS.